Loading...
Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
BACKGROUND: The dose and time point for switching from clopidogrel to ticagrelor remain controversial, especially for Chinese acute coronary syndrome (ACS) patients with complicated coronary artery disease (CAD). Hence, the purpose of this study was to further explore the optimal dose and time point...
Na minha lista:
| Udgivet i: | Chin Med J (Engl) |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Health
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6819042/ https://ncbi.nlm.nih.gov/pubmed/31567375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000000444 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|